Treatment of Isoniazid-Resistant Pulmonary Tuberculosis

Mostrar otras versiones (1)

Tuberculosis (TB) remains a threat to public health and is the leading cause of death globally. Isoniazid (INH) is an important first-line agent for the treatment of TB considering its early bactericidal activity. Resistance to INH is now the most common type of resistance. Resistance to INH reduces...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhun, Byung Woo, Koh, Won-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953491/
https://www.ncbi.nlm.nih.gov/pubmed/31905429
http://dx.doi.org/10.4046/trd.2019.0065

Ejemplares similares

Ejemplares similares